EpiBiome is a precision microbiome engineering company whose mission is to surveil bacterial populations and to develop effective and sustainable FDA-approved therapies to combat infectious diseases in humans and in agriculture without the use of shared-class antibiotics. Instead of antibiotics, the company deploys non-GMO, bacteria-specific viruses, abundant in nature and harmless to humans, to address problematic bacteria.

The company’s management team consists of Nick Conley, PhD (Co-founder & Chief Executive Officer), Aeron Tynes Hammack, PhD (Co-founder & Chief Operating Officer), Christina Tsai, PhD (Co-founder & VP of Asian Business Development), Lucia Mokres, DVM (Chief Medical Officer), and Bruno Marchon, PhD (Chief Technical Officer). The management team possesses previous startup and corporate experience, including in research, management, and regulatory affairs.

The full team is extraordinarily multidisciplinary and has few redundant skillsets; between its nine PhD scientists and engineers, two large-animal veterinarians, and MBA, the team holds advanced degrees in all major scientific disciplines: chemistry, physics, biology, and medicine.

EpiBiome has an exceptionally credentialed team of scientific advisors, including Dr. Thomas Shryock, CSO of Antimicrobial Consultants and member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria; Prof. Sylvain Moineau at Laval University (Canada), a preeminent phage researcher who was recently declared by Thomson Reuters to be “one of the most influential scientists in the world”; Prof. Matt Sullivan at Ohio State University, an expert in next-generation phage sequencing and high-throughput phage discovery; Prof. Pamela Contag at Stanford University, co-founder of Xenogen (acquired by Caliper, a Perkin Elmer Company), entrepreneur, and expert in microbiology and small-animal imaging; and Dr. Brent Townshend, a bioengineer, electrical engineer, and inventor of the 56K modem.

Show more

Employee Rating

5.0More
TypePrivate
HQSouth San Francisco, US
Founded2013
Size (employees)10 (est)-16%
Websiteepibiome.com
EpiBiome was founded in 2013 and is headquartered in South San Francisco, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at EpiBiome

Tynes Hammack

Tynes Hammack

Board of Directors
Nick Conley

Nick Conley

Board of Directors
Bruno Marchon

Bruno Marchon

CTO
Thomas Shryock

Thomas Shryock

Scientific Advisory Board
Sylvain Moineau

Sylvain Moineau

Scientific Advisory Board
Matt Sullivan

Matt Sullivan

Scientific Advisory Board
Show more

EpiBiome Office Locations

EpiBiome has an office in South San Francisco
South San Francisco, (HQ)
201 Gateway Blvd
Show all (1)
Report incorrect company information

EpiBiome Financials and Metrics

Summary Metrics

Founding Date

2013

EpiBiome total Funding

$7 m

EpiBiome latest funding size

$1 m

Time since last funding

2 years ago

EpiBiome investors

EpiBiome's latest funding round in June 2016 was reported to be $1 m. In total, EpiBiome has raised $7 m
View all funding rounds
Report incorrect company information

EpiBiome Online and Social Media Presence

Embed Graph
Report incorrect company information

EpiBiome Company Life and Culture

Report incorrect company information

EpiBiome Frequently Asked Questions

  • When was EpiBiome founded?

    EpiBiome was founded in 2013.

  • Who are EpiBiome key executives?

    EpiBiome's key executives are Tynes Hammack, Nick Conley and Bruno Marchon.

  • How many employees does EpiBiome have?

    EpiBiome has 10 employees.

  • Who are EpiBiome competitors?

    Competitors of EpiBiome include NovellusDx, UNUM Therapeutics and Biotech Products Services and Research.

  • Where is EpiBiome headquarters?

    EpiBiome headquarters is located at 201 Gateway Blvd, South San Francisco.

  • Where are EpiBiome offices?

    EpiBiome has an office in South San Francisco.

  • How many offices does EpiBiome have?

    EpiBiome has 1 office.